Product NDC: | 68682-357 |
Proprietary Name: | Dihydroergotamine Mesylate |
Non Proprietary Name: | dihydroergotamine mesylate |
Active Ingredient(s): | 4 mg/mL & nbsp; dihydroergotamine mesylate |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68682-357 |
Labeler Name: | Oceanside Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020148 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20130318 |
Package NDC: | 68682-357-10 |
Package Description: | 8 VIAL in 1 KIT (68682-357-10) > 1 mL in 1 VIAL |
NDC Code | 68682-357-10 |
Proprietary Name | Dihydroergotamine Mesylate |
Package Description | 8 VIAL in 1 KIT (68682-357-10) > 1 mL in 1 VIAL |
Product NDC | 68682-357 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dihydroergotamine mesylate |
Dosage Form Name | SPRAY |
Route Name | NASAL |
Start Marketing Date | 20130318 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Oceanside Pharmaceuticals |
Substance Name | DIHYDROERGOTAMINE MESYLATE |
Strength Number | 4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |